The patients who followed the rules were the ones getting sicker.
Angela Akinpelu, PA-C spent twelve years in labor and delivery rooms, exam rooms, surgical suites, and hospital wards following every protocol — counseling patients to cut the fat, trust the guidelines, and take the next medication on the ladder. They came back with higher A1Cs, longer medication lists, and less of their lives left.
Then her own body began to fail: eighty pounds gained, brain fog so severe she feared dementia, and a food addiction she had carried since she was eight, standing at a locked freezer in her grandmother's basement.
So she did something that put her at odds with the system that trained her. She started prescribing fat — not as a fad or a workaround, but as medicine.
PhatPharm: Fat Is the New Rx is an investigative clinical memoir and a blueprint for metabolic reversal — twenty-seven chapters tracing her investigation from the exam room to the farm bill, from the 1977 dietary guidelines to the mitochondria starving inside every cell.
Part I — The Investigation. Why the most obedient patients decline the fastest. How engineered food is built to override satiety. And why metabolic risk falls unequally: unequal load, not broken biology.
Part II — The Pipeline. How wartime food science became the Standard American Diet. How the diabetes ladder escalates without anyone questioning it. Why appetite suppression can mask metabolic decline. And who profits while patients climb.
Part III — Collateral Damage. The gut, the inflammation spiral, the brain on fire, menopause and andropause and the thyroid — all tracked back to one central engine: the mitochondria. Then the turn the book builds toward: fat as medicine.
Part IV — The Protocol. Keto as clinical therapy. Allulose and the compliance problem. A hybrid model for patients already on GLP-1s. And the bio-individual compass — ApoB, ApoE, advanced lipids — for readers whose numbers refuse to behave the way the textbook says they should.
Part V — The Path Forward. What happens when patients actually get better, what that costs a system built to manage them instead, and why this still isn't standard care.
The book ends where the work begins: a four-phase blueprint — Assessment, Initiation, Optimization, Maintenance — with the labs that matter (starting with the fasting insulin most clinicians never order), the red flags, a metabolic glossary, and a full citations appendix. Every claim carries its source.
Medication decisions stay with your prescriber. The literacy to participate in them belongs to you.
Because the goal was never restriction, deprivation, or the pursuit of thinness. It was this: your biology is not broken. Your instructions are.
Foreword by A.O. David Akinpelu, MD, FACP — twenty-five years at the receiving end of the pipeline, the 3 a.m. emergency room.
